June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Private Equity Acquisition in Ophthalmology and Optometry: A Time Series Analysis of the Pre-COVID, COVID Pre-Vaccine, and COVID Post-Vaccine Eras
Author Affiliations & Notes
  • Sachi A Patil
    Ophthalmology, New York University Grossman School of Medicine, New York, New York, United States
  • Daniel Garrett Vail
    Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai, New York, New York, United States
  • Jacob Tanner Cox
    Ophthalmology, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Evan Chen
    Ophthalmology, University of California San Francisco, San Francisco, California, United States
  • Prithvi Mruthyunjaya
    Ophthalmology, Stanford University School of Medicine, Stanford, California, United States
  • James C Tsai
    Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai, New York, New York, United States
  • Ravi Parikh
    Ophthalmology, New York University Grossman School of Medicine, New York, New York, United States
  • Footnotes
    Commercial Relationships   Sachi Patil None; Daniel Vail None; Jacob Cox None; Evan Chen None; Prithvi Mruthyunjaya None; James Tsai Consultant for Eyenovia, ReNetX Bio, Smartlens, Code F (Financial Support); Ravi Parikh Consultant fees for Anthem, blue cross blue shield , Code C (Consultant/Contractor)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 3091. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Sachi A Patil, Daniel Garrett Vail, Jacob Tanner Cox, Evan Chen, Prithvi Mruthyunjaya, James C Tsai, Ravi Parikh; Private Equity Acquisition in Ophthalmology and Optometry: A Time Series Analysis of the Pre-COVID, COVID Pre-Vaccine, and COVID Post-Vaccine Eras. Invest. Ophthalmol. Vis. Sci. 2023;64(8):3091.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To describe geographic and temporal trends in private equity (PE) backed acquisitions of ophthalmology and optometry practices in the United States from 2012 to 2021.

Methods : Acquisition data was compiled from 6 financial databases, 5 industry news outlets, and publicly available press releases. Financial database search for individual platform and practice acquisitions. Data gathered included number of total acquisitions, practice type, locations, provider details, and geographic footprint.Linear regression models were used to compare rates of acquisition. 245 PE acquisitions of ophthalmology and optometry practices in the United States between 10/21/2019 and 9/1/2021.

Results : 245 practices associated with 614 clinical locations and 948 ophthalmologists or optometrists were acquired by 30 PE-backed platform companies. 18 of 30 platform companies were new compared to our prior study. Of these acquisitions, 127, 29, and 89 were comprehensive, retina, and optometry practices, respectively. Monthly acquisitions increased by 0.947 acquisitions per year (p<0.001*). Texas, Florida, Michigan, and New Jersey were the states with the greatest number of acquisitions with 55, 48, 29, 28 clinic acquisitions, respectively. Average monthly PE acquisitions were 5.71 per month from 1/1/2019 - 2/29/2020 (pre-COVID), 5.30 per month 3/1/2020-12/31/2020 (COVID pre-vaccine, p=0.8072), and were 8.78/month 1/1/2021-9/1/2021 (COVID post-vaccine, p=0.1971).

Conclusions : PE acquisitions increased from 2012-2021 as companies continue to utilize both regionally focused and multi-state models of add-on acquisitions.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×